Clinical trial
Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients…
NCT00390182 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00390182 |
|---|---|
| Title | Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) |
| Official title | GCC 0319: Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) |
| Acronym | GCC0319 |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Neoplasms, Ovarian Neoplasms |
| Intervention type | Drug |
| Interventions | Gemcitabine |
| Enrollment | 38 |
| Start date | Oct 1, 2003 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Oct 19, 2006 |
| Last update posted | Mar 18, 2020 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: